Suppr超能文献

[聚六亚甲基双胍(PHMB)作为白内障手术的术前防腐剂]

[Polyhexamethylbiguanid (PHMB) as preoperative antiseptic for cataract surgery].

作者信息

Hansmann F, Kramer A, Ohgke H, Strobel H, Müller M, Geerling G

机构信息

Klinik für Augenheilkunde des Universitätsklinikums Schleswig-Holstein Lübeck, Campus Lübeck.

出版信息

Ophthalmologe. 2004 Apr;101(4):377-83. doi: 10.1007/s00347-003-0933-9.

Abstract

BACKGROUND

We examined the efficacy and tolerability of Lavasept (polyhexamethylenbiguanid or PHMB)-an iodine-free antiseptic-in comparison to polyvinylpyrolidon iodine and Ringer's solution, as an alternative preoperative antiseptic.

PATIENTS AND METHODS

In a randomized controlled double-blind trial 3 drops of Lavasept, 1.25%, PVP-iodine or Ringer's solution were applied preoperatively in 29 patients. The number of colony forming units (cfu) grown from conjunctival smears and conjunctival hyperaemia, corneal epitheliopathy and ocular surface pain were assessed preoperatively, intraoperatively and 1 day postoperatively.

RESULTS

Despite intraoperative application of PVP-iodine, 40% of patients receiving Ringers solution still presented with more than 5 colony forming units (cfu) at the end of the procedure, while all patients that had additional preoperative Lavasept or PVP-iodine achieved relative sterility with less than 5 cfu (p < 0.05). While the effect of Lavasept lasted until the next day, conjunctival microbial colonisation recurred in eyes treated with PVP-iodine. As expected conjunctival hyperaemia and corneal epitheliopathy increased significantly postoperatively but no differences were observed between the 3 solutions tested.

CONCLUSION

The preoperative application of Lavasept reduces the conjunctival flora safely and effectively. The microbicidal efficacy is equal to PVP-iodine, but potentially longer lasting. No signs of local or systemic intolerability were observed. Lavasept may be used as a potential alternative preoperative antiseptic and is suitable for iodine-intolerant patients.

摘要

背景

我们研究了无碘防腐剂Lavasept(聚六亚甲基双胍或PHMB)与聚乙烯吡咯烷酮碘和林格氏液相比,作为术前防腐剂替代品的有效性和耐受性。

患者和方法

在一项随机对照双盲试验中,对29例患者术前应用3滴1.25%的Lavasept、聚乙烯吡咯烷酮碘或林格氏液。术前、术中及术后1天评估结膜涂片培养出的菌落形成单位(cfu)数量、结膜充血、角膜上皮病变和眼表疼痛情况。

结果

尽管术中应用了聚乙烯吡咯烷酮碘,但接受林格氏液的患者中有40%在手术结束时仍有超过5个菌落形成单位(cfu),而所有术前额外使用Lavasept或聚乙烯吡咯烷酮碘的患者均实现了相对无菌,cfu少于5个(p<0.05)。Lavasept的效果持续到第二天,而用聚乙烯吡咯烷酮碘治疗的眼睛结膜微生物定植复发。正如预期的那样,术后结膜充血和角膜上皮病变显著增加,但在所测试的3种溶液之间未观察到差异。

结论

术前应用Lavasept可安全有效地减少结膜菌群。其杀菌效果与聚乙烯吡咯烷酮碘相当,但可能持续时间更长。未观察到局部或全身不耐受的迹象。Lavasept可作为一种潜在的术前防腐剂替代品,适用于碘不耐受患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验